CIK 0000001800 · Pharmaceutical Preparations (SIC 2834) · NYSE · incorporated in IL · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 44.3 B | 43.7 B |
| Net income (USD) | 6.5 B | 6.9 B |
| Diluted EPS (USD/shares) | 3.72 | 3.91 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-21 | 8-K | 8-K items 2.02,9.01 | 2026-10-21 |
| 2026-10-21 | 8-K | FORM 8-K items 8.01,9.01 | 2026-10-21 |
| 2026-10-02 | 4 | OWNERSHIP DOCUMENT | 2026-09-30 |
| 2026-10-02 | 4 | OWNERSHIP DOCUMENT | 2026-09-30 |
| 2026-10-02 | 4 | OWNERSHIP DOCUMENT | 2026-09-30 |
| 2026-10-02 | 4 | OWNERSHIP DOCUMENT | 2026-09-30 |
| 2026-10-02 | 4 | OWNERSHIP DOCUMENT | 2026-09-30 |
| 2026-09-25 | 4 | 4 | 2026-09-23 |
| 2026-09-03 | 4 | 4 | 2026-09-01 |
| 2026-09-03 | 4 | 4 | 2026-09-01 |
| 2026-09-02 | 144 | 144 | |
| 2026-08-27 | 4 | 4 | 2026-08-25 |
| 2026-08-25 | 144 | 144 | |
| 2026-08-20 | 8-K | FORM 8-K items 7.01,8.01,9.01 | 2026-08-20 |
| 2026-08-13 | 4 | 4 | 2026-08-11 |
| 2026-08-11 | 144 | 144 | |
| 2026-07-28 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-16 | 8-K | 8-K items 2.02,9.01 | 2026-07-16 |
| 2026-07-01 | 4 | 4 | 2026-06-30 |
| 2026-07-01 | 4 | 4 | 2026-06-30 |
| 2026-07-01 | 4 | 4 | 2026-06-30 |
| 2026-07-01 | 4 | 4 | 2026-06-30 |
| 2026-07-01 | 4 | 4 | 2026-06-30 |
| 2026-07-01 | 4 | 4 | 2026-06-30 |
| 2026-06-29 | 4 | 4 | 2026-06-27 |
Forms on file (last 1,000): 4 718, 8-K 88, 144 49, 3 26, 10-Q 25, SC 13G/A 15, DEFA14A 9, 11-K 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ABT (0.002 USD), /gw/filings/filings?ticker=ABT&form=8-K, /gw/filings/facts?ticker=ABT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange